Ajooni Biotech Limited — Important, 09-12-2024: Updates

The Board of Directors of Ajooni Biotech Limited has approved the un-audited financial results for the quarter and half-year ended September 30, 2024. The company reported significant operational metrics, which include a profit before tax of ₹22.56 crore, reflecting their financial health and performance trajectory. Furthermore, total assets increased to ₹8,909.64 crore, driven by growth in current assets, with cash and cash equivalents rising to ₹1,701.83 crore. This robust financial footing presents a positive outlook for strategic investments and operational expansions.

The capital structure improved, with equity share capital increasing to ₹3,444.87 crore, indicating strong investor confidence. The completion of a limited review reaffirms transparency and accuracy in financial reporting. Investors should monitor these developments as they may enhance shareholder value and signify potential growth opportunities in the market.